Skip to main content
International Journal for Quality in Health Care logoLink to International Journal for Quality in Health Care
. 2025 Jan 24;37(1):mzae120. doi: 10.1093/intqhc/mzae120

Supporting equitable access to kidney transplant in remote Western Australia using continuous quality improvement

Felicity Stewart 1, Nicholas Corsair 2, James Stacey 3, Sarah Cox 4, Joshua Bowring 5, Khalil Patankar 6, Iann Lee 7, Kristan Teasdale 8, Emma Griffiths 9,10,*
PMCID: PMC11771395  PMID: 39869417

Abstract

Background: Despite an epidemic of end-stage kidney disease in the Australian Aboriginal and Torres Strait Islander population, disparities in access to kidney transplantation persist. The journey to a successful kidney transplant is long, with an initial suitability assessment required before waitlist-specific activities begin. In an Aboriginal Community Controlled renal service, we aimed to:

(i) design and implement a continuous quality improvement (CQI) approach to transplant suitability assessment,

(ii) provide transplant suitability assessments for all patients of the service,

(iii) describe what temporary contraindications to kidney transplantation should be the focus of health service improvements,

(iv) explore participant experiences with the suitability assessment process, and

(v) use our findings to inform pre- and post-transplant model of care development within Kimberley Renal Services.

Methods: Mixed methods design with file review. Transplant suitability assessment results with descriptive analysis and semi-structured interview with thematic analysis.

Results: Of completed assessments, 20/66 (30%) had no contraindications and were cleared for workup with median time on dialysis prior to assessment of 2.9 years, 42/66 (64%) had temporary contraindications, and 4/66 (6%) had permanent contraindications. Eighty-five temporary contraindications were identified in 46 individuals: 17/46 had both medical and nonmedical contraindications, 5/46 had medical contraindications only, and 24/46 had nonmedical contraindications only. The most common temporary contraindications were smoking (23/46), treatment adherence (17/46), and high body mass index (11/46). Patients wanted more information on the transplant process, and interviewers noted the importance of providing information in an appropriate way. Patients wanted more support to address modifiable health risk factors to improve their chances of future transplantation.

Conclusions: In the first stages of our CQI approach to improving access to kidney transplants for Kimberley Aboriginal people, we achieved substantial catch-up in suitability assessments and a comprehensive summary of factors impacting successful waitlisting. Our results are consistent with, and build upon other work in this space, highlighting the importance of involving Aboriginal staff and patients in education and support for prospective recipients.

Keywords: Aboriginal health, kidney transplant, renal, equity, CQI

Introduction

An epidemic of end-stage kidney disease (ESKD) has been observed among Aboriginal and Torres Strait Islander people in remote areas of Australia. The rates of renal replacement therapy (RRT) use are eight to nine times higher and ESKD occurs on average ∼30 years earlier [1]. Given the existing burden of early chronic kidney disease [1], and risk factors for progressive disease [2], effective and culturally safe renal care [3] for Aboriginal and Torres Strait Islander people will need to be a health services priority for years to come.

For many patients across remote Australia, accessing haemodialysis entails forced relocation from family and country with negative impacts on physical and mental health [4]. Kidney transplants can help some patients return to their preferred place of residence with a better quality of life and increased life expectancy [5, 6]. In the Kimberley region, as in the rest of the country, Aboriginal and Torres Strait Islander patients experience more delays in care that impact on access to transplantation [7, 8]. As a result, the percentage of First Nations people with kidney failure who receive a transplant is very low relative to the number receiving dialysis [9]. Access to the waitlist itself presents the main barrier to transplantation for Aboriginal people rather than access to a transplant once waitlisted [10].

The journey to a successful transplant is long, and the root causes of access inequity are complex and multifactorial. Before a patient even begins waitlist-specific activities, many factors are considered by the treating nephrologist to determine whether a patient is a suitable candidate [10]. In Australia, only patients who have commenced dialysis are eligible to be listed to receive a deceased donor kidney transplant. Exclusion criteria for kidney transplantation are further outlined in the Transplantation Society of Australia and New Zealand (TSANZ) guidelines [11]; however, the risks and benefits of transplantation are considered on an individual basis by the practitioners involved in their care. Aboriginal and Torres Strait Islander patients on RRT have higher rates of medical comorbidities, which may impact suitability; however, data have suggested that this does not fully explain the transplant equity gap [7]. Other factors considered include those known to increase the likelihood of complications in transplant outcomes (such as smoking or obesity) and those associated with a risk of ‘non-adherence to complex medical management’ such as limited social support, missed medications, or missed dialysis sessions.

The National Indigenous Kidney Transplant Taskforce (NIKTT) was established in 2019 by the Commonwealth of Australia Department of Health to improve access to, and outcomes of, kidney transplantation for Aboriginal and Torres Strait Islander people. The Taskforce recommended the development of programmes to facilitate better access to transplantation, with a particular focus on improving the health of Aboriginal and Torres Strait Islander people so they can be waitlisted [12]. Kimberley Renal Services (KRS) is an Aboriginal Community Controlled renal service that provides pre- and post-transplant support to Aboriginal people. This report describes the first results of a real-world, continuous quality improvement (CQI) project aiming to ensure all patients were formally assessed for transplant suitability, in line with the recommendations made by the NIKTT [13] and the National Strategic Action Plan for Kidney Disease [14].

Methods

Setting

The Kimberley region of Western Australia is remote with a large Aboriginal population (2021: 14 408 people, 41% of the total population) [15]. KRS provides Aboriginal Community Controlled renal services at 4 rural and remote sites with 165 satellite haemodialysis positions as of February 2024. The dialysis population in the Kimberley is young, with 78% of patients aged <65 years compared to 48% in the Australian dialysis population [9]. Medical care for dialysis patients is provided in partnership between the visiting nephrology team, local nurses, and general practitioners. Nephrology and transplant services are coordinated from the state capital, >2000 km away. The KRS transplant coordinator provides pre- and post-transplant care coordination and delivery of patient education sessions. Education is offered to prospective future transplant candidates. Content is tailored to need and delivered both individually, and in group sessions.

Continuous quality improvement design

A plan-do-study-act (PDSA) [16] approach was taken to the design of the CQI programme (Fig. 1), with the long-term target of achieving transplant suitability assessment for 100% of KRS RRT patients within 6 months of their admission to the service and 80% of patients up to date with reassessment as indicated. The PDSA approach was selected due to a history of successful use in the Aboriginal Community Controlled Health Sector, as described in the National Framework for Continuous Quality Improvement in Primary Health Care for Aboriginal and Torres Strait Islander People 2018–23 [17].

Figure 1.

Figure 1

CQI framework for transplant suitability assessment.

At the beginning of the project, the only formal mechanism for recording transplant suitability was via the Australia and New Zealand Dialysis and Transplant (ANZDATA) registry: the ‘ANZDATA reported status’ [18]. This reporting activity, which is undertaken annually for all patients undergoing RRT, did not include a systematic assessment or provide recommendations for patient or provider actions to improve suitability. To achieve our target, and to maintain our results over time, we have identified and incorporated into our design the need to:

  • develop, pilot, and refine a transplant suitability assessment tool;

  • develop, pilot, and refine a tool for reporting against our CQI target; and

  • integrate the above into the electronic medical record system used for clinical service delivery (MMEx, ISA technologies).

Participants

Patients were eligible for inclusion in the study if they were an Aboriginal and/or Torres Strait Islander person receiving RRT in the Kimberley region. New patients were added to the list throughout the study on admission. Patients were excluded if they were non-Indigenous, had previously declined transplant workup after a full discussion with the treating nephrologist, had documented permanent contraindications to transplant, were in residential aged care, had an advanced care plan inconsistent with undergoing major surgery, or were already waitlisted. The inclusion of suitability assessment data is restricted to eligible patients who provided individual informed consent.

Health staff involved in the CQI elements of this study include nephrologists employed with the visiting specialist services (n = 3), general practitioners employed with KRS who had been caring for haemodialysis patients for many years (n = 2), the KRS transplant coordinator (a registered nurse), and KRS educators and support staff (Aboriginal health workers and non-clinical care co-ordinators) (n = 5). Those health staff completing aspects of the CQI process were those involved in the usual transplant suitability assessment pathways for the patients as per the real-world design of the study.

Data collection and analysis

Transplant suitability

Prior to study commencement, there was no transplant suitability assessment tool available at KRS or via the visiting nephrology service. A tool was developed with reference to Australian guidelines (TSANZ [11] and Caring for Australians and New Zealanders with Renal Impairment (CARI) [19]) and international guidelines, Kidney Disease Improving Global Outcomes (KDIGO) [20], and with input from the tertiary nephrology service, after a scoping review failed to identify any similar tools in the public domain (Table 1). This was piloted and refined prior to use with consenting patients.

Table 1.

Data collection tools: KRS transplant suitability assessment tool and interviewer guide.

Section Content
Transplant suitability assessment
Cardiac and peripheral vascular disease History and investigation results
Malignancy History and investigation results
Infection History and investigation results
Metabolic Diabetes: Y/N; type of diabetes; complications; glycaemic control
BMI
Comorbidities Respiratory/gastrointestinal/neurological/musculoskeletal/frailty/other
Non-medical factors Substance use:
  • Current smoker Y/N

  • Heavy alcohol use Y/N

  • Illicit drug use Y/N


Social supports: Carer identified Y/N
Treatment adherence:
  • Missed dialysis sessions last 3 months:

  • Reasons for missed sessions:

  • Other treatment concerns:


Patient interest in transplant: Y/N; Details;
Contraindications For any condition identified above:
Contraindications: Yes/No, permanent or temporary
Suitability status GREEN: No contraindication identified, commence work-up
ORANGE: Temporary contraindication, review at (months): 3/6/other
RED: Permanent contraindication, review only as indicated
Patient feedback: semi-structured interview guide
Has anyone ever talked to you about how it works to get a renal transplant/new kidney? Yes/No/Don’t know; Patient comments;
Have you ever been to a group education/yarning session about getting a renal transplant/new kidney? Yes/No/Don’t know; Patient comments;
Are you interested in getting a renal transplant/new kidney? Yes/No/Don’t know; Patient comments;
Do you know whether you are suitable/can have workup for transplant? Yes/No/Don’t know; Patient comments;
Do you know if there is anything you need to change/work on before you can get a renal transplant/new kidney? Yes/No/Don’t know; Patient comments;
If Yes: How is it going with [the things the patient is working on]?
If DIFFICULT/HAVING PROBLEMS: How can we help you/what would help you with [the things the patient is working on]?
Do you have any other feedback/comments/things to say about the process for getting a renal transplant/new kidney? Patient comments:

The tool was filled in by the KRS transplant coordinator and KRS general practitioners for all consenting patients, summarizing medical history and health risk factors. It was finalized by a visiting nephrologist at the time of their 3-monthly face-to-face assessment of the patient. The completing nephrologist was asked to identify any contraindications to transplant workup progression, assign a suitability status and review interval. A contraindication was defined as anything that prevented the nephrologist from recommending the patient commence transplant workup. If contraindications to transplant were identified, it was noted whether they were permanent (‘red’ status—without capacity for improvement, review on request only) or temporary (‘orange’ status—temporary contraindications identified, for later review). If no contraindications to commencement of workup were identified, they were assigned a ‘green’ status.

Time on dialysis was calculated from the commencement of any dialysis modality to the day of transplant suitability assessment. The difference in age and time on dialysis between suitability status groups was analysed by a Mann–Whitney test (given not meeting criteria for normality), significance level at P = .05. Descriptive quantitative analysis was then performed with data cleaning in Microsoft Excel (©Microsoft Corporation) before analysis in Stata (Release 18, ©Statacorp).

Patient feedback

Consenting patients were given the opportunity to provide feedback on the project via a short, semi-structured interview (Table 1—interview guide). Interviews were conducted after suitability assessments were complete. All interviews were conducted by KRS staff members (n = 5) who were either Aboriginal or had lived experience of the transplant journey. Thematic analysis of semi-structured interview results was conducted inclusive of research staff (n = 2) and interviewers. Where interview staff consented for their quotes to be included, they are presented verbatim in the results section (Interviewer feedback).

Other related project activities

Transplantation education was delivered to 37 patients during the study period. Concurrent to this project, an outreach assessment clinic project funded by the NIKTT provided three 1-week visits of specialist clinical outreach to the region that provided additional specialist nephrology access for components of this project [21]. Transplant surgeons and specialized transplant nurses also attended outreach trips.

Results

Suitability status assessments

One hundred and seventy-six patients were considered for inclusion. Seventeen were non-Indigenous, one already waitlisted, and 16 were excluded (Fig. 2), leaving 142 eligible patients.

Figure 2.

Figure 2

Inclusion and exclusion criteria, with assessment outcome for included patients.

Seventy-nine patients consented to participate, of which 31 had previously had an ANZDATA reported suitability status. A total of 66 participants completed suitability assessments between January 2021 and January 2022, with 16 participant interviews completed between May and September 2022 (Table 2). Participants came from 14 different communities from across the Kimberley. Median age was 53.7 (interquartile range (IQR) 48.3–57.8) and 28 (42%) were male. Median time on dialysis was 4.3 years (IQR 2.0–8.2).

Table 2.

Participant details.

  n %
Age at assessment (years)
15–24 2 3
25–34 2 3
35–44 8 12
45–54 26 40
55–64 22 33
≥65 6 9
Time on dialysis
<1 year 9 14
1–2 7 10
2–3 9 14
3–4 4 6
4–5 8 12
>5 29 44
Cause of ESKD
Diabetic nephropathy 47 71
Hypertensive nephropathy 6 9
Focal Segmental Glomerulosclerosis 2 3
Glomerulonephritis 2 3
IgA nephropathy 2 3
Unknown 2 3
Othera 5 8
Suitability status
Green (no contraindication identified) 20 30
Orange (temporary contraindication/s identified) 42 64
Red (permanent contraindication/s identified) 4 6
Total 66 100
a

Includes congenital and obstructive uropathies, reflex nephropathy, and systemic lupus erythematosus.

The most common medical comorbidity was diabetes [51/66 patients (83%), 30 of whom had extra-renal microvascular complications], followed by cardiovascular disease [34/66 (52%)], chronic infections [15/66 (23%)], and frailty [8/66 (12%)]. The most common infectious comorbidity noted was diabetic foot disease with or without osteomyelitis (9/15).

When assessed, 20/66 patients (30%) had no contraindications and were cleared for workup, 42/66 (64%) had temporary contraindications, and 4/66 (6%) had permanent contraindications. There was no statistically significant difference in median age (53 vs 55 years, P = .72) or time on dialysis (4.7 vs 2.9 years, P = .15) between those with or without contraindications. Of the 20 people without identified contraindication to workup, 8 had been on dialysis for more than 5 years, with the longest time being 9.4 years.

Eighty-five temporary contraindications were identified in 46 individuals: 17/46 patients had both medical and nonmedical contraindications, 5/46 had medical contraindications only, and 24/46 had nonmedical contraindications only. The most common temporary contraindications were smoking (23/46 patients), treatment adherence (17/46), and high body mass index (BMI) (11/46). Only four had permanent contraindications including frailty and cardiac disease.

Patient feedback

Sixteen patients [62.5% female, median age 51 years (IQR 56–63)] provided feedback on their experiences with kidney transplant suitability assessment and workup.

People wanted more information

Participants wanted to know more about the transplant process, especially those who had not attended an education session. They wanted more time with the transplant coordinator and more follow-up from the transplant team. People wanted more positive talk about transplant processes to come from their dialysis service, lists of what needed to be done, and where to get support:

They need to let us know how it works. We need to know … how it work and go about it. (Participant 2)

Always waiting or forgotten

Patients felt they were always waiting to hear back about their progress. One patient remembered overhearing the doctors discussing transplant with other patients, but not them, which made them feel left out. Several patients expressed having no idea what was happening to them, or not being informed about their care.

… waiting nine years to hear. I didn’t know that I wasn’t on the waitlist automatically but you are not, you have to go through the process. (Participant 7)

Knowing what, but not how to make changes

Some patients were aware of changes they needed to make to improve their suitability for transplant but found these difficult to action. Several said they needed more support but were not sure where this could come from. Positive talk, yarning circles and education sessions at dialysis, as well as changes to the home environment to promote health were identified as helpful. More generally, activities that distracted from boredom and facilitated connection to Country were desired.

At this time … the hardest thing for me to do is quit smoking. (Participant 6)

Interviewer feedback

Interviewers emphasized the great interest from patients in receiving information on the transplant process and the need to deliver it in an appropriate way: consistently and using different modalities such as visual examples. The side effects of dialysis could make patients forgetful [‘dialysis brain’ (Patient Care Assistant)] and patients needed to hear things more than once.

It’s life-changing … and they need the information in a way they understand … break it down real simple. (Aboriginal Care Coordinator)

Interviewers noted that Aboriginal involvement was needed throughout, from the first assessment of suitability through to assistance navigating the tertiary health system, which scared many of the patients. They described the challenges some patients faced balancing health care appointments with other family and cultural commitments:

It’s not always the patient’s fault … a lot of people have family commitments, they might be waiting and waiting [at their primary care service] … but then they have their granddaughter or daughter with grandkids and they need a hand. (Patient Care Assistant)

Interviewers recommended regular contact between patients and the transplant support team: ‘Just checking in, everyone wants to be checked in on’ (Patient Care Assistant). For those who were displaced from their home Country to access dialysis services, return to Country was a strong motivator, and interview staff identified this as key to supporting positive change: ‘once they get home their minds are going to change’ (Aboriginal Care Coordinator).

Discussion

Statement of principal findings

In this article, we present the efforts of an Aboriginal Community Controlled Health Service to advance equitable access to transplant suitability assessment. Timely assessment is an important issue for patients of this service: many had spent years without being properly assessed, consistent with the longer median time to transplant experienced by Aboriginal people [22].

A CQI approach achieved a substantial increase in the proportion of patients assessed. The systematic approach to assessment comprehensively identified where actions could be taken to improve their chances of future transplantation, unlike previous approaches to assessment that were driven more by reporting requirements. Future development of the CQI process now requires the development of the electronic medical record system to facilitate data entry and real-time reporting.

We described medical comorbidities and contraindications to transplantation in our study group, with the aim of informing health service improvements. As predicted, diabetic nephropathy as a cause of ESKD was more common in our population. Diabetic foot disease was the most common chronic infection identified as a possible concern for transplant, highlighting the importance of podiatry input for ESKD patients on dialysis. Most contraindications preventing the commencement of transplant workup were, however, not medical comorbidities, but health risk factors such as smoking, treatment adherence, and high BMI. Patients wanted more information on the transplant process, and interviewers noted the importance of providing information in an appropriate way. Feedback from patients and interviewers in this study affirms that any model of care aiming to achieve equitable access to kidney transplant must promote and support effective communication between patient and provider on the background of a trusted relationship.

Strengths and limitations

The strengths of this study were the close integration of the research and clinical teams, the CQI-based approach, and a relatively large sample size from a majority Aboriginal patient population. We encountered some challenges in implementing our project. In part due to COVID-19 travel restrictions, half our patients were either not able to be consulted for informed consult or were incompletely assessed (Fig. 2), limiting our capacity to present whole-of-service results. Our results are based on the medical information known at the time of patient review—as a patient progresses through transplant workup, investigations may reveal other contraindications to transplant, and those are not captured here. Our participants were exclusively rural and remote-living Aboriginal and/or Torres Strait Islanders, and we would not assume the pattern of suitability or contraindications to be generalizable to other populations. However, the process of transplant suitability assessment could be usefully shared with other centres and adapted to their needs.

Interpretation within the context of the wider literature

The most common contraindications to transplant identified in this study are usually considered modifiable, but without sufficient support change can be hard to achieve. Weight loss is especially difficult to achieve on dialysis. In one study specifically aiming to support weight loss for kidney transplantation, multidisciplinary support without bariatric surgery achieved low rates of waitlisting at 12 months [23]. In addition, although overweight is associated with worse outcomes after transplantation, weight loss is also associated with mortality [24], and the evidence to guide safe and effective weight loss for dialysis patients is limited [25].

Appropriate delivery of transplant-related education and information was a priority for patients. Effective delivery of these services requires the implementation of culturally safe kidney care recommendations that have been developed in partnership with Aboriginal and Torres Strait Islander people [4, 26, 27]. Principles of cultural safety in renal service delivery have been proposed based on a growing body of literature that increasingly prioritizes Aboriginal voices [28]: in summary: self-reflection, communication, minimization of power-differential, and decolonization and ensuring individuals are not diminished, demeaned, or disempowered. The role of patient navigators in enabling patients to more successfully understand and manage their transplant journey has been demonstrated in recent pilot studies [29, 30], which provide useful frameworks for further development. Additionally, when patients who have received a kidney transplant are included in education delivery as ‘peer educators’, their lived experience can help ensure education content is relevant and culturally appropriate. That lived experience is of particular benefit given the fear many patients feel when anticipating the major surgery required for a transplant [31].

Implications for policy, practice, and research

The next phase of this project will focus on implementing required changes to workflow, workforce, and the electronic medical record system. Principles of cultural safety will inform ongoing improvements in renal service delivery, including education and support both before and after a kidney transplant. More evidence is required to guide individual goal setting for potential transplant recipients advised to lose weight for surgery, and programmes to safely support physical activity and fitness are needed. Pre- and post-transplant outcomes must continue to be monitored transparently with successful initiatives appropriately supported and resourced.

Conclusion

In the first stages of our CQI approach to improving access to kidney transplants for Kimberley Aboriginal people, we achieved substantial catch-up in suitability assessments and a comprehensive summary of factors impacting successful waitlisting for our patients. New reporting systems currently in design will provide the infrastructure needed for regular CQI cycles to monitor activity. These results are consistent with and build upon other works in this space, including those highlighting the importance of involving Aboriginal staff and patients in education and support for prospective kidney transplant recipients.

Acknowledgements

The authors thank Johan Rosman (data collection)2, David Atkinson (project development)3, Julia Marley (project development)3, Cohen Dean1 (data collection and analysis), and Sarah Coombes1 (data collection and analysis).

Contributor Information

Felicity Stewart, Kimberley Renal Services, PO Box 1377, Broome, Western Australia 6725, Australia.

Nicholas Corsair, Kimberley Renal Services, PO Box 1377, Broome, Western Australia 6725, Australia.

James Stacey, Kimberley Renal Services, PO Box 1377, Broome, Western Australia 6725, Australia.

Sarah Cox, Kimberley Renal Services, PO Box 1377, Broome, Western Australia 6725, Australia.

Joshua Bowring, Kimberley Renal Services, PO Box 1377, Broome, Western Australia 6725, Australia.

Khalil Patankar, Nephrology Department, Royal Perth Hospital, 197 Wellington Street Perth, WA 6000, Australia.

Iann Lee, The Rural Clinical School of Western Australia, 12 Napier Terrace Broome, Western Australia 6725, Australia.

Kristan Teasdale, The Rural Clinical School of Western Australia, 12 Napier Terrace Broome, Western Australia 6725, Australia.

Emma Griffiths, Kimberley Renal Services, PO Box 1377, Broome, Western Australia 6725, Australia; The Rural Clinical School of Western Australia, 12 Napier Terrace Broome, Western Australia 6725, Australia.

Funding

No funding was allocated specifically for the CQI activities outlined in this manuscript. The NIKTT funded 3 weeklong outreach clinics to the region during the study period which provided additional availability for the nephrologist to assess patients. KRS was not the administrator of this grant but did receive some time-limited funds towards the KRS transplant coordinator position (see Ref. [17]).

Conflict of interest

F.S., N.C., J.S., S.C., J.B., and E.G. were employees of KRS during the study period and provided clinical and/or support care to the participants. K.P. was employed by Royal Perth Hospital visiting the region and provided clinical nephrology services.

Data availability

In deference to principles of Indigenous Data Sovereignty, access to the data collected as part of this project is available only through processes owned by the Aboriginal Community Controlled Health Services that supported this project. Requests for data access can be directed to the corresponding author.

Ethics and other permissions

A process of informed consent was followed. This project was approved by the Kimberley Aboriginal Health Planning Forum after receiving letters of support from all Kimberley Aboriginal Community Controlled Health Organisations. Ethics approval was granted by the Western Australian Aboriginal Health Ethics Committee. Aboriginal staff members were consulted on the suitability of language used in the patient feedback survey and it was revised accordingly. All surveys were administered with at least one Aboriginal staff member present, and these staff members were invited to provide their input into the interpretation of results.

REFERENCES

  • 1. Hoy  WE, Mott  SA, Mc Donald  SP. An expanded nationwide view of chronic kidney disease in Aboriginal Australians. Nephrology  2016;21:916–22.doi: 10.1111/nep.12798 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Australian Institute of Health and Welfare . Determinants of Health for Indigenous Australians 2024. https://www.aihw.gov.au/reports/australias-health/social-determinants-and-indigenous-health (7 January 2025, date last accessed)
  • 3. Tunnicliffe  DJ, Bateman  S, Arnold-Chamney  M  et al.  Recommendations for culturally safe clinical kidney care for First Nations Australians: a guideline summary. Med J Aust  2023;219:374–85.doi: 10.5694/mja2.52114 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Hughes  JT, Freeman  N, Beaton  B  et al.  My experiences with kidney care: a qualitative study of adults in the Northern Territory of Australia living with chronic kidney disease, dialysis and transplantation. PLoS One  2019;14:e0225722.doi: 10.1371/journal.pone.0225722 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Tonelli  M, Wiebe  N, Knoll  G  et al.  Systematic review: kidney transplantation compared with dialysis in clinically relevant outcomes. Am J Transplant  2011;11:2093–109.doi: 10.1111/j.1600-6143.2011.03686.x [DOI] [PubMed] [Google Scholar]
  • 6. Bateman  S, Owen  K, Lester  R  et al.  The survival benefit of deceased donor kidney transplantation for Aboriginal and Torres Strait Islander people, 2006–20: a retrospective national cohort study. Med J Aust  2024;221:111–6.doi: 10.5694/mja2.52361 [DOI] [PubMed] [Google Scholar]
  • 7. Khanal  N, Lawton  PD, Cass  A  et al. Disparity of access to kidney transplantation by Indigenous and non-Indigenous Australians. Med J Aust  2018;209:261–6. [DOI] [PubMed] [Google Scholar]
  • 8. Majoni  SW, Abeyaratne  A. Renal transplantation in indigenous Australians of the Northern Territory: closing the gap. Intern Med J  2013;43:1059–66.doi: 10.1111/imj.12274 [DOI] [PubMed] [Google Scholar]
  • 9. Australia and New Zealand Dialysis and Transplant Registry. ANZDATA 46th annual report 2023 (data to 2022). 2022.
  • 10. Hughes  JT, Cundale  K, Owen  KJ  et al. Advancing accessible kidney transplantation for Aboriginal and Torres Strait Islander people: the National Indigenous Kidney Transplantation Taskforce. Med J Aust  2023;219:S3–6. [DOI] [PubMed] [Google Scholar]
  • 11. The Transplantation Society of Australia and New Zealand . TSANZ Clinical Guidelines, Chapter 5: Kidney Version 1.12.  https://tsanz.com.au/clinical-guidelines (7 January 2025, date last accessed)
  • 12. National Indigenous Kidney Transplantation Taskforce . Position statement: transplantation equity for Aboriginal and Torres Strait Islander peoples with kidney disease. Adelaide, 2022. [Google Scholar]
  • 13. Garrard  E, and McDonald  S. Improving Access to and Outcomes of Kidney Transplantation for Aboriginal and Torres Strait Islander People in Australia: Performance Report. https://www.anzdata.org.au/wp-content/uploads/2019/07/TSANZ-Performance-Report-Improving-Indigenous-Transplant-Outcomes-Final-edited-1.pdf (7 January 2025, date last accessed)
  • 14. Kidney Health Australia . National Strategic Action Plan for Kidney Disease 2019. https://www.kidney.org.au (31 August 2024, date last accessed).
  • 15. Australian Bureau of Statistics . Kimberley 2021 Census All Persons: People and Population 2021. https://www.abs.gov.au/census/find-census-data/quickstats/2021/51001
  • 16. Clinical Excellence Commission . Model for Improvement & PDSA Cycles. https://www.cec.health.nsw.gov.au/CEC-Academy/quality-improvement-tools/model-for-improvement-and-pdsa-cycles (28 November 2024, date last accessed)
  • 17. National Aboriginal Community Controlled Health Organisation . National framework for continuous quality improvement in primary health care for Aboriginal and Torres Strait Islander people 2018–2023. Canberra, 2018. [Google Scholar]
  • 18. Australia and New Zealand Dialysis and Transplant Registry . For Professionals: FAQ’s. https://www.anzdata.org.au/anzdata/for-professionals/ (14 August 2024, date last accessed).
  • 19. Campbell  S, Pilmore  H, Gracey  D  et al. KHA-CARI guideline: recipient assessment for transplantation. Nephrology  2013;18:455–62.doi: 10.1111/nep.12068 [DOI] [PubMed] [Google Scholar]
  • 20. Chadban  SJ, Ahn  C, Axelrod  DA  et al.  KDIGO clinical practice guideline on the evaluation and management of candidates for kidney transplantation. Transplantation  2020;104:S11–103. [DOI] [PubMed] [Google Scholar]
  • 21. Cundale  K, McDonald  SP, Irish  A  et al.  Improving equity in access to kidney transplantation: implementing targeted models of care focused on improving timely access to waitlisting. Med J Aust  2023;219:S7–10.doi: 10.5694/mja2.52099 [DOI] [PubMed] [Google Scholar]
  • 22. Tiong  MK, Thomas  S, Fernandes  DK  et al. Examining barriers to timely waitlisting for kidney transplantation for Indigenous Australians in Central Australia. Intern Med J  2022;52:288–94.doi: 10.1111/imj.14960 [DOI] [PubMed] [Google Scholar]
  • 23. Kukla  A, Diwan  T, Smith  BH  et al.  Guiding kidney transplantation candidates for effective weight loss: a clinical cohort study. Kidney360  2022;3:1411–6.doi: 10.34067/KID.0001682022 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Quero  M, Montero  N, Rama  I  et al. Obesity in renal transplantation. Nephron  2021;145:614–23.doi: 10.1159/000515786 [DOI] [PubMed] [Google Scholar]
  • 25. Conley  MM, McFarlane  CM, Johnson  DW  et al. Interventions for weight loss in people with chronic kidney disease who are overweight or obese. Cochrane Database Syst Rev  2021;3:CD013119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Kelly  J, Stevenson  T, Arnold-Chamney  M  et al.  Aboriginal patients driving kidney and healthcare improvements: recommendations from South Australian community consultations. Aust N Z J Public Health  2022;46:622–9.doi: 10.1111/1753-6405.13279 [DOI] [PubMed] [Google Scholar]
  • 27. Hughes  JT, Owen  KJ, Kelly  J  et al.  Cultural bias in kidney care and transplantation: review and recommendations to improve kidney care for Aboriginal and Torres Strait Islander people. Med J Aust  2023;219:S11–4. [DOI] [PubMed] [Google Scholar]
  • 28. Arnold-Ujvari  M, Rix  E, Kelly  J. The emergence of cultural safety within kidney care for Indigenous Peoples in Australia. Nurs Inq  2024;31:e12626.doi: 10.1111/nin.12626 [DOI] [PubMed] [Google Scholar]
  • 29. Flinders and Upper North Local Health Network Incorporated . On track to transplant. Final report, 2021.
  • 30. Cairns and Hinterland Hospital and Health Service (CHHHS) and Torres and Cape Hospital and Health Service (TCHHS). Tracks to transplant. Final report. NIKTT, 2022.
  • 31. Watters  TK, Glass  BD, and Mallett  AJ. Identifying the barriers to kidney transplantation for patients in rural and remote areas: a scoping review. J Nephrol  2023;37:1425–1447.doi: 10.1007/s40620-023-01755-0 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

In deference to principles of Indigenous Data Sovereignty, access to the data collected as part of this project is available only through processes owned by the Aboriginal Community Controlled Health Services that supported this project. Requests for data access can be directed to the corresponding author.


Articles from International Journal for Quality in Health Care are provided here courtesy of Oxford University Press

RESOURCES